These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 26867317

  • 1. [Physicochemical Property of iRGD Peptide Modified Doxorubicin Loaded Liposome and Its Effect on Cancer Cell Growth].
    Zhang ZQ, Zhong CL, Zhao X.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 46(6):837-41. PubMed ID: 26867317
    [Abstract] [Full Text] [Related]

  • 2. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
    Yu KF, Zhang WQ, Luo LM, Song P, Li D, Du R, Ren W, Huang D, Lu WL, Zhang X, Zhang Q.
    Int J Nanomedicine; 2013 Nov; 8():2473-85. PubMed ID: 23885174
    [Abstract] [Full Text] [Related]

  • 3. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
    Zhao B, Fan YC, Wang XQ, Dai WB, Zhang Q, Wang XL.
    Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
    [Abstract] [Full Text] [Related]

  • 4. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
    Dai W, Fan Y, Zhang H, Wang X, Zhang Q, Wang X.
    Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
    [Abstract] [Full Text] [Related]

  • 5. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X, Widjaya AS, Liu J, Liu X, Long Z, Jiang Y.
    Acta Biomater; 2020 Apr 01; 106():301-313. PubMed ID: 32081779
    [Abstract] [Full Text] [Related]

  • 6. Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer.
    Peng ZH, Kopeček J.
    J Am Chem Soc; 2015 Jun 03; 137(21):6726-9. PubMed ID: 25963409
    [Abstract] [Full Text] [Related]

  • 7. Hyperthermia-triggered drug delivery from iRGD-modified temperature-sensitive liposomes enhances the anti-tumor efficacy using high intensity focused ultrasound.
    Deng Z, Xiao Y, Pan M, Li F, Duan W, Meng L, Liu X, Yan F, Zheng H.
    J Control Release; 2016 Dec 10; 243():333-341. PubMed ID: 27984104
    [Abstract] [Full Text] [Related]

  • 8. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity.
    Tang J, Zhang L, Gao H, Liu Y, Zhang Q, Ran R, Zhang Z, He Q.
    Drug Deliv; 2016 May 10; 23(4):1130-43. PubMed ID: 25491241
    [Abstract] [Full Text] [Related]

  • 9. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
    Sriraman SK, Pan J, Sarisozen C, Luther E, Torchilin V.
    Mol Pharm; 2016 Feb 01; 13(2):428-37. PubMed ID: 26702994
    [Abstract] [Full Text] [Related]

  • 10. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q, Deng W, Yuan X, Wang H, Ma Z, Wu B, Zhang X.
    Eur J Pharm Biopharm; 2018 Jan 01; 122():87-95. PubMed ID: 29032193
    [Abstract] [Full Text] [Related]

  • 11. Cationic Polymethacrylate-Modified Liposomes Significantly Enhanced Doxorubicin Delivery and Antitumor Activity.
    Wang W, Shao A, Zhang N, Fang J, Ruan JJ, Ruan BH.
    Sci Rep; 2017 Feb 22; 7():43036. PubMed ID: 28225062
    [Abstract] [Full Text] [Related]

  • 12. [Preparation and evaluation of RGD and TAT co-modified paclitaxel loaded liposome].
    Gao B, Mu W.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug 22; 39(8):769-74. PubMed ID: 25202944
    [Abstract] [Full Text] [Related]

  • 13. The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation.
    Wang Y, Huang X, Chen H, Wu Q, Zhao Q, Fu D, Liu Q, Wang Y.
    Molecules; 2023 Sep 09; 28(18):. PubMed ID: 37764308
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R, Zhong T, Zhang WQ, Song P, Song WD, Zhao Y, Wang C, Tang YQ, Zhang X, Zhang Q.
    Int J Nanomedicine; 2014 Sep 09; 9():3091-105. PubMed ID: 25028548
    [Abstract] [Full Text] [Related]

  • 15. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M, Xu Y, Qiu L.
    J Liposome Res; 2017 Jun 09; 27(2):151-160. PubMed ID: 27250110
    [Abstract] [Full Text] [Related]

  • 16. Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity.
    Biswas S, Dodwadkar NS, Deshpande PP, Parab S, Torchilin VP.
    Eur J Pharm Biopharm; 2013 Aug 09; 84(3):517-25. PubMed ID: 23333899
    [Abstract] [Full Text] [Related]

  • 17. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
    Liu M, Ma W, Zhao D, Li J, Li Q, Liu Y, Hao L, Lin Y.
    ACS Appl Mater Interfaces; 2021 Jun 09; 13(22):25825-25835. PubMed ID: 34038071
    [Abstract] [Full Text] [Related]

  • 18. Dual targetable drug delivery system based on cell membrane camouflaged liposome for enhanced tumor targeting and improved anti-tumor efficiency.
    Duan M, Zhou D, Ke J, Chen Y, Wu W, Li Y, Ren J, Wang L, Zhang Z, Wang C.
    Colloids Surf B Biointerfaces; 2024 Jun 09; 238():113892. PubMed ID: 38581834
    [Abstract] [Full Text] [Related]

  • 19. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
    Wang K, Zhang X, Liu Y, Liu C, Jiang B, Jiang Y.
    Biomaterials; 2014 Oct 09; 35(30):8735-47. PubMed ID: 25023394
    [Abstract] [Full Text] [Related]

  • 20. Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma.
    Deng C, Zhang Q, Fu Y, Sun X, Gong T, Zhang Z.
    ACS Appl Mater Interfaces; 2017 Jan 18; 9(2):1280-1292. PubMed ID: 28009503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.